Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis JM Trauer, MY Qian, JS Doyle, SMW Rajaratnam, D Cunnington Annals of internal medicine 163 (3), 191-204, 2015 | 1088 | 2015 |
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 548* | 2021 |
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 490 | 2019 |
Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and … MW Traeger, SE Schroeder, EJ Wright, ME Hellard, VJ Cornelisse, ... Clinical Infectious Diseases 67 (5), 676-686, 2018 | 457* | 2018 |
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis EJ Aspinall, D Nambiar, DJ Goldberg, M Hickman, A Weir, E Van Velzen, ... International journal of epidemiology 43 (1), 235-248, 2014 | 443 | 2014 |
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis EJ Aspinall, S Corson, JS Doyle, J Grebely, SJ Hutchinson, GJ Dore, ... Clinical Infectious Diseases 57 (suppl_2), S80-S89, 2013 | 408 | 2013 |
Preparing a health care workforce for the 21st century: the challenge of chronic conditions World Health Organization World Health Organization, 2005 | 394* | 2005 |
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model N Scott, ES McBryde, A Thompson, JS Doyle, ME Hellard Gut 66 (8), 1507-1515, 2017 | 166 | 2017 |
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade N Scott, JS Doyle, DP Wilson, A Wade, J Howell, A Pedrana, A Thompson, ... International Journal of Drug Policy 47, 107-116, 2017 | 147 | 2017 |
Epidemiology of infections acquired in intensive care units JS Doyle, KL Buising, KA Thursky, LJ Worth, MJ Richards Seminars in respiratory and critical care medicine 32 (02), 115-138, 2011 | 146 | 2011 |
Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia AR Tramontana, B George, AC Hurt, JS Doyle, K Langan, AB Reid, ... Emerging infectious diseases 16 (7), 1068, 2010 | 139 | 2010 |
Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care T Papaluca, L McDonald, A Craigie, A Gibson, P Desmond, D Wong, ... Journal of Hepatology 70 (5), 839-846, 2019 | 106 | 2019 |
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 101 | 2022 |
Eradication of hepatitis C infection: the importance of targeting people who inject drugs M Hellard, JS Doyle, R Sacks‐Davis, AJ Thompson, E McBryde Hepatology 59 (2), 366-369, 2014 | 98 | 2014 |
Outcomes of treatment for hepatitis C in primary care, compared to hospital-based care: a randomized, controlled trial in people who inject drugs AJ Wade, JS Doyle, E Gane, C Stedman, B Draper, D Iser, SK Roberts, ... Clinical Infectious Diseases 70 (9), 1900-1906, 2020 | 96 | 2020 |
Murray Valley encephalitis: a review of clinical features, diagnosis and treatment J Knox, R Cowan, J Doyle, M Ligtermoet, J Archer, J Burrow, S Tong, ... Medical Journal of Australia 196, 322-326, 2012 | 90 | 2012 |
Prescribing trends before and after implementation of an antimicrobial stewardship program KA Cairns, AWJ Jenney, IJ Abbott, MJ Skinner, JS Doyle, M Dooley, ... Medical Journal of Australia 198 (5), 262-266, 2013 | 75 | 2013 |
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings RK Gupta, CJ Calderwood, A Yavlinsky, M Krutikov, M Quartagno, ... Nature medicine 26 (12), 1941-1949, 2020 | 73 | 2020 |
Hepatitis C transmission and treatment as prevention–The role of the injecting network M Hellard, E McBryde, RS Davis, DA Rolls, P Higgs, C Aitken, ... International Journal of Drug Policy 26 (10), 958-962, 2015 | 71 | 2015 |
The cascade of care for an Australian community-based hepatitis C treatment service AJ Wade, DM Macdonald, JS Doyle, A Gordon, SK Roberts, AJ Thompson, ... PloS one 10 (11), e0142770, 2015 | 70 | 2015 |